Nissha Co.ltd. · TSE:7915

Nissha Co.ltd — Q1 FY2024 Earnings Presentation

9 slides from Nissha Co.ltd's earnings presentation, May 9, 2024

  1. Slide 1: Financial Results for FY2024 Q1

    Financial Results for FY2024 Q1 Ended March 31, 2024 May 9, 2024 Junya Suzuki President and CEO Nissha Co., Ltd.

  2. Slide 2: Highlights

    Highlights FY2024 Q1 Results  Tailwinds  Increased in net sales and profit both YoY and QoQ: Net sales increased in all businesses, demand environment improved  Industrial Materials: Steady product demand for both decoration and metallized paper  Devices: Demand for tablet devices increased as e

  3. Slide 3: FY2024 Q1 (3 months) Results

    FY2024 Q1 (3 months) Results (Millions of JPY) 2023 Q1 2023 Q4 2024 Q1 Results Results Results YoY QoQ Net sales 42,430 43,840 46,719 +10.1% +6.6% Industrial Materials 17,073 17,729 17,841 +4.5% +0.6% Devices 14,807 13,877 16,569 +11.9% +19.4% Medical Technologies 8,525 9,755 10,069 +18.1% +3.2% Oth

  4. Slide 4: Industrial Materials: FY2024 Q1 Results, Q2 Forecast

    Industrial Materials: FY2024 Q1 Results, Q2 Forecast Quarterly net sales and operating profit margin ■Sustainable Materials ●Operating profit margin ●Operating profit margin Q1 Results (Forex: ¥145/$) (Metallized paper and others) ■Decoration (Home appliances (excluding impairment loss)  Decoratio

  5. Slide 5: Devices: FY2024 Q1 Results, Q2 Forecast

    Devices: FY2024 Q1 Results, Q2 Forecast Quarterly net sales and operating profit margin ■Gaming devices, Handheld terminals (logistics Q1 Results (Forex: ¥145/$) related), Mobility, Gas sensors and others ■Tablet devices ■Smartphones ●Operating profit margin  Tablet devices: Net sales increased du

  6. Slide 6: Medical Technologies: 2024 Q1 Results, Q2 Forecast

    Medical Technologies: 2024 Q1 Results, Q2 Forecast Quarterly net sales and operating profit margin  Q1 Results (Forex: ¥145/$) ■Business media ●Operating profit margin  Medical devices (CDMO) ■Medical devices (Own brand)  Acquired company (Isometric) contributed to ■Medical devices (CDMO) the con

  7. Slide 7: Forecast has been revised upward

    Forecast has been revised upward (Millions of JPY) Previous Forecast (February 14) Revised Forecast (May 9) FY2024 FY2024 FY2024 FY2024 FY2024 FY2024 Full-year H1 H2 Full-year H1 H2 Forecast Forecast Forecast Forecast Forecast Forecast Net sales 186,500 91,500 95,000 188,600 93,600 95,000 Industrial

  8. Slide 8: (Reference) Capital investment, Depreciation and amortization, M&A investment, R&D (FY2024)

    (Reference) Capital investment, Depreciation and amortization, M&A investment, R&D (FY2024) (Millions of JPY) Q1 Results Capital investment 2,043 Depreciation and amortization 2,269 M&A investment 10,218 R&D 1,086 ©2024 Nissha Group 8

  9. Slide 9: Cautionary note on forward-looking information

    Among the information included in this presentation and provided at investor briefings and conferences, performance targets, plans, outlooks, strategies and other information that is not constituted of actual past facts, is information that has been judged reasonable by the managers of the Company b

Nissha — Q1 FY2024 Earnings Presentation on 6ix